RESUMEN
The aims of the present work were to perform a comparative study of the effects of delta sleep-inducing peptide and Deltaran on neurons in emotiogenic brain structures and to address the question of whether it is possible to prevent or decrease the negative influences of stress loads on the severity of subsequent cerebral ischemia in rats, using glycine with delta sleep-inducing peptide combined in the neuroprotective formulation Deltaran. The results showed that Deltaran and delta sleep-inducing peptide had largely the same actions on the nature of spike activity of neurons in the dorsal hippocampus, paraventricular nucleus of the hypothalamus, and ventral anterior nuclei of the thalamus, evoking activation of some of the neurons in these brain structures. The dorsal hippocampus was dominated by activation of spike activity in response to administration of delta sleep-inducing peptide; Deltaran produced activation mainly in the paraventricular nuclei of the hypothalamus. In all animals given Deltaran, the index of brain blood supply was significantly greater than in animals not given Deltaran. The survival rate of cerebral ischemia was 100% in animals given Deltaran. Death occurred in 38% of animals not given Deltaran.
Asunto(s)
Isquemia Encefálica/prevención & control , Encéfalo/efectos de los fármacos , Péptido Inductor del Sueño Delta/farmacología , Glicina/farmacología , Neurotransmisores/farmacología , Estrés Psicológico/tratamiento farmacológico , Potenciales de Acción/efectos de los fármacos , Glándulas Suprarrenales/patología , Animales , Encéfalo/irrigación sanguínea , Encéfalo/fisiopatología , Isquemia Encefálica/complicaciones , Isquemia Encefálica/mortalidad , Combinación de Medicamentos , Hipocampo/efectos de los fármacos , Masculino , Tamaño de los Órganos/efectos de los fármacos , Núcleo Hipotalámico Paraventricular/efectos de los fármacos , Ratas , Ratas Wistar , Restricción Física , Estrés Psicológico/complicaciones , Estrés Psicológico/mortalidad , Estrés Psicológico/fisiopatología , Tálamo/efectos de los fármacos , Timo/patologíaRESUMEN
A seizure-protecting effect of the delta-sleep-inducing peptide (DSIP) and its analogues was revealed. An intensive sorption of H3 tryptophan occurred under the effect of the DSIP and its analogues. The data obtained suggests that the serotoninergic system plays no important part in the seizure-protecting effect.
Asunto(s)
Anticonvulsivantes/farmacología , Péptido Inductor del Sueño Delta/análogos & derivados , Péptido Inductor del Sueño Delta/farmacología , Receptores de Serotonina/efectos de los fármacos , Animales , Anticonvulsivantes/administración & dosificación , Convulsivantes , Péptido Inductor del Sueño Delta/administración & dosificación , Evaluación Preclínica de Medicamentos , Epilepsia Generalizada/inducido químicamente , Epilepsia Generalizada/tratamiento farmacológico , Hipocampo/efectos de los fármacos , Hipocampo/fisiología , Ácido Kaínico , Masculino , Picrotoxina , Ratas , Ratas Wistar , Receptores de Serotonina/fisiología , Sustancia Negra/efectos de los fármacos , Sustancia Negra/fisiología , Tritio , Triptófano/metabolismoRESUMEN
The effects of delta-sleep inducing peptide (DSIP) and its analogues (1-4) administered into substantia nigra pars reticulata on locomotor and seizure activity were estimated in experiments in rats. It was shown that intranigral microinjection of DSIP as well as DSIP-1-DSIP-4 caused decreasing of horizontal, vertical locomotor activity and attendance of central sectors of the "open field". Antiseizure effects, i.e. the first and clonic-tonic picrotoxin-induced convulsive latent period lengthening and their intensity decreasing, revealed DSIP, DSIP-2 and DSIP-3. Authors suppose that changes of DSIP structure lead to changes of effects expression on locomotor and seizure activity in conditions of their administration into substantia nigra reticulata. Obtained data concerning protective effects of studied peptides on experimental seizure syndrome allow to conclude that there is interaction between DSIP-induced hypokinesia and DSIP analogues anticonvulsive effectiveness in case of their intranigral administration which is likelihood is one of the component of nigral-dependent seizure-suppressive mechanism.
Asunto(s)
Anticonvulsivantes/farmacología , Péptido Inductor del Sueño Delta/análogos & derivados , Péptido Inductor del Sueño Delta/farmacología , Actividad Motora/efectos de los fármacos , Convulsiones/tratamiento farmacológico , Animales , Anticonvulsivantes/administración & dosificación , Péptido Inductor del Sueño Delta/administración & dosificación , Evaluación Preclínica de Medicamentos , Masculino , Microinyecciones , Actividad Motora/fisiología , Picrotoxina , Ratas , Ratas Wistar , Tiempo de Reacción/efectos de los fármacos , Tiempo de Reacción/fisiología , Convulsiones/inducido químicamente , Convulsiones/fisiopatología , Sustancia NegraRESUMEN
Dynamics of the hypokinesia-induced changes of free radical and malonic dialdehyde content in brain, the changes of respiratory chain state and superoxide dismutase activity in liver of rats has been studied using ESR technique and biochemical methods. The effect of the preliminary injection of DSIP and its analogue ID-2 on these dynamics has also been studied. Using a model system constants of the interaction between DSIP or ID-2 and O2-. have been determined. The data point to the antioxidant effect of the administration of the peptides before hypokinesia. This suggests that the effect involves in mechanisms of the anti-stress action of these peptides.
Asunto(s)
Péptido Inductor del Sueño Delta/análogos & derivados , Péptido Inductor del Sueño Delta/uso terapéutico , Hipotálamo/efectos de los fármacos , Inmovilización/fisiología , Mitocondrias Hepáticas/efectos de los fármacos , Estrés Psicológico/tratamiento farmacológico , Animales , Evaluación Preclínica de Medicamentos , Transporte de Electrón/efectos de los fármacos , Radicales Libres , Hipotálamo/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Mitocondrias Hepáticas/metabolismo , Ratas , Restricción Física , Estrés Psicológico/etiología , Estrés Psicológico/metabolismo , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismoAsunto(s)
Péptido Inductor del Sueño Delta/fisiología , Epilepsia/fisiopatología , Animales , Anticonvulsivantes/uso terapéutico , Conducta Animal/efectos de los fármacos , Conducta Animal/fisiología , Encéfalo/efectos de los fármacos , Encéfalo/fisiopatología , Péptido Inductor del Sueño Delta/farmacología , Péptido Inductor del Sueño Delta/uso terapéutico , Evaluación Preclínica de Medicamentos , Epilepsia/tratamiento farmacológico , Excitación Neurológica/efectos de los fármacos , Excitación Neurológica/fisiología , Convulsiones/tratamiento farmacológico , Convulsiones/fisiopatología , Estrés Psicológico/fisiopatologíaRESUMEN
Frequency spectra of brain electrograms in the course of 1 h after peripheral and central administration of the delta-sleep peptide (DSIP) or two its analogues were studied in freely moving rats. In autumn series of experiments carried out on 18 animals was revealed the phase action of DSIP being manifested in initial (up to 20 min after the injection) suppression of fast (20-26 Hz) oscillations in electrocorticograms and their augmentation in subsequent intervals. Under the identical conditions analogues of DSIP induced the effects characteristic for different phases of DSIP action. In spring-summer series of experiments carried out in 6 animals was revealed a significant increase of the delta-waves in electrical activity of the Putamen after intraperitoneal injection of DSIP and its first analogue. Under the conditions of intraventricular injection DSIP induced stable augmentation of oscillations in a diapason of 14-16 Hz in the neocortex, and its analogues induced similar changes in a nearby frequency diapason of 9.6-11 Hz.
Asunto(s)
Encéfalo/efectos de los fármacos , Péptido Inductor del Sueño Delta/análogos & derivados , Péptido Inductor del Sueño Delta/farmacología , Electroencefalografía/efectos de los fármacos , Animales , Encéfalo/fisiología , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/fisiología , Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/fisiología , Electrodos Implantados , Electroencefalografía/instrumentación , Electroencefalografía/métodos , Hipocampo/efectos de los fármacos , Hipocampo/fisiología , Hipotálamo/efectos de los fármacos , Hipotálamo/fisiología , Masculino , Ratas , Ratas Wistar , Estaciones del Año , Vigilia/efectos de los fármacos , Vigilia/fisiologíaRESUMEN
The delta-sleep-inducing peptide (DSIP) suppressed seizure activity in the cat cortical strychnine-induced seizure foci. The DSIP delayed development of corazol kindling in rats, prevented seizure induced with bicucullin and other agents in mice. The DSIP effect was shown to be realised through the action upon reticular black substance. The DSIP seems to take part in endogenous control of the brain excitability.
Asunto(s)
Péptido Inductor del Sueño Delta/uso terapéutico , Convulsiones/tratamiento farmacológico , Animales , Química Encefálica/efectos de los fármacos , Gatos , Péptido Inductor del Sueño Delta/administración & dosificación , Péptido Inductor del Sueño Delta/análisis , Evaluación Preclínica de Medicamentos , Electroencefalografía/efectos de los fármacos , Excitación Neurológica/efectos de los fármacos , Excitación Neurológica/fisiología , Masculino , Mesencéfalo/química , Mesencéfalo/efectos de los fármacos , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos CBA , Ratas , Ratas Wistar , Convulsiones/inducido químicamente , Convulsiones/metabolismo , Factores de TiempoRESUMEN
The experiments on C57Bl mice with metastatic Lewis lung carcinoma have shown that peptide delta-sleep (DSIP) lowers the stimulation of metastatic spreading which is observed in combination of the surgical removal of the tumour with the emotional-painful stress. The antimetastatic effect is accompanied by stabilization of neurohumoral indices, by a decrease in the intensity of lipid peroxidation and of the acid cathepsin activity in the blood vessels and in the lung tissue.
Asunto(s)
Carcinoma/fisiopatología , Péptido Inductor del Sueño Delta/uso terapéutico , Neoplasias Pulmonares/fisiopatología , Estrés Psicológico/tratamiento farmacológico , Animales , Encéfalo/metabolismo , Evaluación Preclínica de Medicamentos , Metabolismo de los Lípidos , Masculino , Ratones , Ratones Endogámicos C57BL , Metástasis de la Neoplasia , Trasplante de Neoplasias , Neurotransmisores/metabolismo , Oxidación-Reducción/efectos de los fármacos , Estrés Psicológico/fisiopatología , Factores de TiempoRESUMEN
Intercentral relations between hypothalamus, limbic system and reticular formation were studied in rabbits and rats under systemic and central action of DSIP, ACTH, corticosteroids and stress (aggressive-defensive behaviour). The results obtained demonstrate changes in the adrenal cortex resulting from stress-inducing adrenocortical hormone content. The increase was achieved by the rise in ACTH level resulting in corticosteroid level elevation (endogenous elevation-aggressive behaviour) and by corticosteroid injections (exogenous elevation). Correlation analysis of structural interrelations after ACTH and corticosteroid injections demonstrated an increased correlation between hypothalamo-reticular-limbic structures. DSIP was shown to have an opposite effect. Correlation analysis revealed the potentials for the formation of new functional interrelations between hypothalamo-reticular-limbic structure in the motivation of aggression (stress) and the levels of corticosterone and DSIP. DSIP action depends on the initial corticosteroid blood level and is more marked in stress-inducing concentrations.
Asunto(s)
Hormona Adrenocorticotrópica/farmacología , Péptido Inductor del Sueño Delta/farmacología , Hipotálamo/fisiología , Formación Reticular/fisiología , Estrés Fisiológico/fisiopatología , Hormona Adrenocorticotrópica/sangre , Animales , Frío , Péptido Inductor del Sueño Delta/sangre , Electroencefalografía , Hipotálamo/efectos de los fármacos , Masculino , Conejos , Formación Reticular/efectos de los fármacosRESUMEN
Homocarnosine, at a dose of 10 mg per 100 g of animal body mass administered intraperitoneally within 15 min before hyperbaric oxygenation with 0.7 MPa of oxygen, exhibited a protective effect. After administration of the neuropeptide into animals before hyperbaric oxygenation a latent period of oxygen convulsions was increased; content of homocarnosine and gamma-aminobutyric acid (GABA) was maintained at the level found in brain of control animals. In brain tissue of unprotected animals content of homocarnosine and GABA was decreased due to the oxygen treatment. GABA was less effective, its protective dose exceeded 10-fold the dose of homocarnosine. The neuropeptide exhibited antioxidant properties in reactions of lipid peroxidation under normal conditions and in hyperbaric oxygenation in vitro. The antioxidant activity of GABA was distinctly lower as compared with homocarnosine.